BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,703,000 | +24.1% | 46,057 | +26.1% | 0.10% | +66.7% |
Q3 2018 | $1,372,000 | -51.9% | 36,530 | -49.4% | 0.06% | -47.2% |
Q2 2018 | $2,853,000 | +1.7% | 72,200 | -33.7% | 0.11% | +13.7% |
Q1 2018 | $2,806,000 | +8.5% | 108,939 | +13.7% | 0.10% | +26.7% |
Q4 2017 | $2,585,000 | – | 95,822 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |